Loading...
Pilot-scale Production of Hydrolysates with Altered Bio-functionalities based on Thermally-denatured Whey Protein Isolate
O'Loughlin, Ian B. Murray, Brian A. Fitzgerald, Richard J. Brodkorb, Andre Kelly, Philip
O'Loughlin, Ian B.
Murray, Brian A.
Fitzgerald, Richard J.
Brodkorb, Andre
Kelly, Philip
Citations
Altmetric:
Date
13/08/2013
Collections
Research Projects
Organizational Units
Journal Issue
Citation
I.B. O'Loughlin, B.A. Murray, R.J. FitzGerald, A. Brodkorb, P.M. Kelly. Pilot-scale production of hydrolysates with altered bio-functionalities based on thermally-denatured whey protein isolate. International Dairy Journal, 2014, 34(1), 146-152. DOI: 10.1016/j.idairyj.2013.07.009.
Abstract
Whey protein isolate (WPI) solutions (100 g L−1 protein) were subjected to a heat-treatment of 80 °C for 10 min. Unheated and heat-treated WPI solutions were hydrolysed with Corolase® PP at pilot-scale to either 5 or 10% degree of hydrolysis (DH). Hydrolysates were subsequently processed via cascade membrane fractionation using 0.14 μm, and 30, 10, 5 and 1 kDa cut-off membranes. The compositional and molecular mass distribution profiles of the substrate hydrolysates and membrane processed fractions were determined. Whole and fractionated hydrolysates were assayed for both angiotensin-I-converting enzyme (ACE) inhibitory activity and ferrous chelating capabilities. A strong positive correlation (P < 0.01) was established between the average molecular mass of the test samples and the concentration needed to chelate 50% of the iron (CC50) in solution. The lowest ACE inhibition concentration (IC50 = 0.23 g L−1 protein) was determined for the 1 kDa permeate of the heat-treated 10% DH hydrolysate